Effective diabetes care: a need for realistic targets

doi:10.1136/bmj.324.7353.1577

BMJ 2002;324:1577-1580 ( 29 June )

Education and debate

Effective diabetes care: a need for realistic targets

Peter H Winocour, consultant physician.

Department of Diabetes and Endocrinology, Queen Elizabeth II Hospital, Welwyn Garden City, Herts AL7 4HQ

peter.winocour@qeii.enherts-tr.nhs.uk

The first 150 words of the full text of this article appear below.

The research based metabolic and blood pressure targets that the national service framework for diabetes in England and Waleswill set in the implementation document will be impractical foruse in routine clinical care: targets need to be tailored to theindividual patient, according to Peter Winocour

The publication of the national service framework for diabetes in England and Wales will raise public awareness of diabetesthroughout the United Kingdom. Its recommendations are influencedby evidence that adverse vascular outcomes may be reduced by tightcontrol of blood sugar and blood pressure^1-3 and that secondaryprevention of macrovascular disease is feasible through modificationof dyslipidaemia and use of antiplatelet agents^4-7^w1; and by the recognition of an estimated doubling in incidenceof diabetes over the next 10 years.⁸

This has led to the production of guidelines for optimal care that may be incorporated into a nationally recommended standardisedapproach, with targets . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

Tough targets are necessary in effective diabetes care: Tahseen A Chowdhury and Shawarna S Lasker
BMJ 2002 325: 775. [Extract] [Full Text]

NSF targets for diabetes are impractical
BMJ 2002 324: 0. [Full Text]

This article has been cited by other articles:

Cleveringa, F. G.W., Gorter, K. J., van den Donk, M., Rutten, G. E.H.M. (2008). Combined Task Delegation, Computerized Decision Support, and Feedback Improve Cardiovascular Risk for Type 2 Diabetic Patients: A cluster randomized trial in primary care. Diabetes Care 31: 2273-2275 [Abstract] [Full text]
Bebb, C., Coupland, C., Stewart, J., Kendrick, D., Madeley, R., Sturrock, N., Burden, R., for the Nottingham Diabetes Blood Pressure Study, (2007). Practice and patient characteristics related to blood pressure in patients with type 2 diabetes in primary care: a cross-sectional study. Fam Pract 24: 547-554 [Abstract] [Full text]
Austin, R. P. (2006). Polypharmacy as a Risk Factor in the Treatment of Type 2 Diabetes. Diabetes Spectr. 19: 13-16 [Full text]
Kumar, R., Winocour, P. H (2005). Review: Dual blockade of the renin angiotensin system in diabetes -- rationale and risks. British Journal of Diabetes & Vascular Disease 5: 266-271 [Abstract]
Schaars, C. F., Denig, P., Kasje, W. N., Stewart, R. E., Wolffenbuttel, B. H.R., Haaijer-Ruskamp, F. M. (2004). Physician, Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management in Type 2 Diabetic Patients in Primary Care. Diabetes Care 27: 123-128 [Abstract] [Full text]
Kerr, D. (2003). Of Struldbruggs, sugar, and gatekeepers: a tale of our times. BMJ 327: 1451-1453 [Full text]
Cosgrove, M. (2003). A survey of the number of medications taken by patients 70 years of age and over with diabetes. British Journal of Diabetes & Vascular Disease 3: 361-363 [Abstract]
Cosgrove, M., Hunter, J. (2003). Auditing diabetes values in primary care. British Journal of Diabetes & Vascular Disease 3: 368-371 [Abstract]
Schwartz, S., Sievers, R., Strange, P., Lyness, W. H., Hollander, P. (2003). Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: Efficacy, safety, and cost analysis. Diabetes Care 26: 2238-2243 [Abstract] [Full text]
Denver, E. A., Barnard, M., Woolfson, R. G., Earle, K. A. (2003). Management of Uncontrolled Hypertension in a Nurse-Led Clinic Compared With Conventional Care for Patients with Type 2 Diabetes. Diabetes Care 26: 2256-2260 [Abstract] [Full text]
Sawicki, P. T, Kaiser, T. (2003). Reply: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?. British Journal of Diabetes & Vascular Disease 3: 285-285
Ballinger, P. (2003). Do all diabetic patients need statins? A view from primary care. British Journal of Diabetes & Vascular Disease 3: 58-61 [Abstract]
Fisher, M. (2003). Prevention of macrovascular complications. Eur Heart J Suppl 5: B21-B26 [Abstract]
Chowdhury, T. A, Lasker, S. S (2002). Tough targets are necessary in effective diabetes care. BMJ 325: 775-775 [Full text]
Reasner, C. A, Goke, B. (2002). Overcoming the barriers to effective glycaemic control for type 2 diabetes. British Journal of Diabetes & Vascular Disease 2: 290-295

Rapid Responses:

Read all Rapid Responses

At Last - A National Institute for Pragmatism?: Keith A Hopcroft
bmj.com, 2 Jul 2002 [Full text]
Effective diabetes care: Yan San Dr. Lee
bmj.com, 3 Jul 2002 [Full text]
targets can be reached: david J kinshuck
bmj.com, 4 Jul 2002 [Full text]
EFFECTIVE DIABETES CARE: TOUGH TARGETS ARE NECESSARY: Tahseen A Chowdhury, et al.
bmj.com, 26 Jul 2002 [Full text]
The value of guidelines.: Nitin Shori
bmj.com, 29 Jul 2002 [Full text]
Will failing to meet targets fail accreditation?: john sharvill
bmj.com, 8 Oct 2002 [Full text]